Artificial Intelligence (AI)-based Clinical Trials Market Insights, Country, Share, Competitors Research Study to 2029


Data Bridge Market Research analyses that the artificial intelligence (AI)-based clinical trials market which was USD 1.3 billion in 2021, would rocket up to USD 5.55 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029.

Artificial Intelligence (AI)-based Clinical Trials Market

 

Industry Analysis

Data Bridge Market Research analyses that the artificial intelligence (AI)-based clinical trials market which was USD 1.3 billion in 2021, would rocket up to USD 5.55 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029.

 

 

Market Insights

  • The market for artificial intelligence (AI)-based clinical trials will expand by 21.7 percent over the next five years. The demand for AI-based clinic trial is anticipated to see a solid recovery soon and expand favourably over the long term. In the near future, the Artificial Intelligence (AI)-based clinical trials market business will present rewarding opportunities.
  • In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
  • Artificial intelligence can be used to identify disease, provide healthcare services, and even develop new treatments, while improving clinical trials. The scale and speed of AI are significantly superior to any system that depends just on human activity. In many ways, this will be the biggest problem moving forward because we haven't yet reached an AI level that can run totally autonomously.

 

Industry Segmentation

The Artificial Intelligence (AI)-based clinical trials market is segmented on the basis of clinical trial phase, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Clinical Trial Phase

 

  • Phase-I
  • Phase-II
  • Phase-III

Application

  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases or Conditions
  • Infectious Diseases
  • Others

End-user

  • Pharmaceutical Companies
  • Academia
  • Others

 

Get a Free Sample of The Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artificial-intelligence-ai-based-clinical-trials-market

 

 

Market Country Level Analysis

  • The countries covered in the Artificial Intelligence (AI)-based clinical trials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
  • North America dominates the Artificial Intelligence (AI)-based clinical trials market. This growth can be attributed to many factors including surge in the number of clinical trials carried out in the region.
  • Asia-Pacific is expected to grow exhibit lucrative growth over the forecast period due to the rising penetration of AI-based tools and favourable government initiatives for the adoption of AI in different healthcare fields.

Get full access to the report: https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-ai-based-clinical-trials-market

 

Industry Share Analysis

Some of the major players operating in the Artificial Intelligence (AI)-based clinical trials market are:

  • Phesi (India)
  • CONSILX (Singapore)
  • DEEP LENS Inc. (U.S.)
  • Unlearn.AI, Inc. (U.S.)
  • Saama Technologies, LLC (U.S.)
  • Antidote Technologies, Inc. (U.K.)
  • Innoplexus (Germany)
  • Mendel.ai (U.S.)
  • Median Technologies (France)
  • Symphony AI (U.S.)
  • BioAge Labs, Inc. (U.S.)
  • AiCure (U.S.)
  • Halo Health Systems (U.S.)

 

Major TOC of the Report

  • Chapter One: Introduction
  • Chapter Two: Industry analysis
  • Chapter Three: Market Overview
  • Chapter Four: Industry segmentation
  • Chapter Five: Industry share analysis

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-intelligence-ai-based-clinical-trials-market

 

 

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
                                                                                                                                                                     

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818  
Email: Sopan.gedam@databridgemarketresearch.com

 

Browse Related Reports@

Global Plastics Gap Packaging Filler Market

Middle East and Africa Food Allergens and Intolerance Testing Market

India Writing and Printing and Specialty Paper Market

North America Food Allergens and Intolerance Testing Market

North America Rice Husk Ash Market

Global Professional Dental Care Market

Global Dental Implants and Prosthetics Market

Global Smart Diabetes Management Market

 

 

Enter with Facebook Login